133 related articles for article (PubMed ID: 25728416)
1. Iminopyrimidinones: a novel pharmacophore for the development of orally active renin inhibitors.
McKittrick BA; Caldwell JP; Bara T; Boykow G; Chintala M; Clader J; Czarniecki M; Courneya B; Duffy R; Fleming L; Giessert R; Greenlee WJ; Heap C; Hong L; Huang Y; Iserloh U; Josien H; Khan T; Korfmacher W; Liang X; Mazzola R; Mitra S; Moore K; Orth P; Rajagopalan M; Roy S; Sakwa S; Strickland C; Vaccaro H; Voigt J; Wang H; Wong J; Zhang R; Zych A
Bioorg Med Chem Lett; 2015 Apr; 25(7):1592-6. PubMed ID: 25728416
[TBL] [Abstract][Full Text] [Related]
2. Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors.
Scheiper B; Matter H; Steinhagen H; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2011 Sep; 21(18):5480-6. PubMed ID: 21840218
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel human renin inhibitors through a combined approach of pharmacophore modelling, molecular DFT analysis and in silico screening.
Gogoi D; Baruah VJ; Chaliha AK; Kakoti BB; Sarma D; Buragohain AK
Comput Biol Chem; 2017 Aug; 69():28-40. PubMed ID: 28552695
[TBL] [Abstract][Full Text] [Related]
5. Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor.
Shultz MD; Cheung AK; Kirby CA; Firestone B; Fan J; Chen CH; Chen Z; Chin DN; Dipietro L; Fazal A; Feng Y; Fortin PD; Gould T; Lagu B; Lei H; Lenoir F; Majumdar D; Ochala E; Palermo MG; Pham L; Pu M; Smith T; Stams T; Tomlinson RC; Touré BB; Visser M; Wang RM; Waters NJ; Shao W
J Med Chem; 2013 Aug; 56(16):6495-511. PubMed ID: 23844574
[TBL] [Abstract][Full Text] [Related]
6. Discovery of highly potent renin inhibitors potentially interacting with the S3' subsite of renin.
Sun X; Wen X; Chen YY; Shi C; Gao C; Wu Y; Wang LJ; Yang XH; Sun H
Eur J Med Chem; 2015 Oct; 103():269-88. PubMed ID: 26363506
[TBL] [Abstract][Full Text] [Related]
7. Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors.
Hua Z; Bregman H; Buchanan JL; Chakka N; Guzman-Perez A; Gunaydin H; Huang X; Gu Y; Berry V; Liu J; Teffera Y; Huang L; Egge B; Emkey R; Mullady EL; Schneider S; Andrews PS; Acquaviva L; Dovey J; Mishra A; Newcomb J; Saffran D; Serafino R; Strathdee CA; Turci SM; Stanton M; Wilson C; Dimauro EF
J Med Chem; 2013 Dec; 56(24):10003-15. PubMed ID: 24294969
[TBL] [Abstract][Full Text] [Related]
8. Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC.
Rose Y; Ciblat S; Reddy R; Belley AC; Dietrich E; Lehoux D; McKay GA; Poirier H; Far AR; Delorme D
Bioorg Med Chem Lett; 2006 Feb; 16(4):891-6. PubMed ID: 16298129
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of new orally active nonpeptidic inhibitors of human neutrophil elastase.
Ohmoto K; Yamamoto T; Horiuchi T; Imanishi H; Odagaki Y; Kawabata K; Sekioka T; Hirota Y; Matsuoka S; Nakai H; Toda M; Cheronis JC; Spruce LW; Gyorkos A; Wieczorek M
J Med Chem; 2000 Dec; 43(26):4927-9. PubMed ID: 11150162
[No Abstract] [Full Text] [Related]
10. Novel alkynyl substituted 3,4-dihydropyrimidin-2(1H)-one derivatives as potential inhibitors of chorismate mutase.
Mallikarjuna Rao V; Mahesh Kumar P; Rambabu D; Kapavarapu R; Shobha Rani S; Misra P; Pal M
Bioorg Chem; 2013 Dec; 51():48-53. PubMed ID: 24012092
[TBL] [Abstract][Full Text] [Related]
11. Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors.
Scheiper B; Matter H; Steinhagen H; Stilz U; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2010 Nov; 20(21):6268-72. PubMed ID: 20850300
[TBL] [Abstract][Full Text] [Related]
12. Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseases.
Politi A; Durdagi S; Moutevelis-Minakakis P; Kokotos G; Papadopoulos MG; Mavromoustakos T
Eur J Med Chem; 2009 Sep; 44(9):3703-11. PubMed ID: 19410337
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel non-peptidic ketopiperazine-based renin inhibitors.
Holsworth DD; Powell NA; Downing DM; Cai C; Cody WL; Ryan JM; Ostroski R; Jalaie M; Bryant JW; Edmunds JJ
Bioorg Med Chem; 2005 Apr; 13(7):2657-64. PubMed ID: 15755665
[TBL] [Abstract][Full Text] [Related]
15. Potential virtual lead identification in the discovery of renin inhibitors: application of ligand and structure-based pharmacophore modeling approaches.
Thangapandian S; John S; Sakkiah S; Lee KW
Eur J Med Chem; 2011 Jun; 46(6):2469-76. PubMed ID: 21497958
[TBL] [Abstract][Full Text] [Related]
16. Optimization of orally bioavailable alkyl amine renin inhibitors.
Xu Z; Cacatian S; Yuan J; Simpson RD; Jia L; Zhao W; Tice CM; Flaherty PT; Guo J; Ishchenko A; Singh SB; Wu Z; McKeever BM; Scott BB; Bukhtiyarov Y; Berbaum J; Mason J; Panemangalore R; Cappiello MG; Bentley R; Doe CP; Harrison RK; McGeehan GM; Dillard LW; Baldwin JJ; Claremon DA
Bioorg Med Chem Lett; 2010 Jan; 20(2):694-9. PubMed ID: 19959358
[TBL] [Abstract][Full Text] [Related]
17. Novel, potent and orally bioavailable indolizidinone-derived inhibitors of the hepatitis C virus NS3 protease.
Clarke MO; Byun D; Chen X; Doerffler E; Leavitt SA; Sheng XC; Yang CY; Kim CU
Bioorg Med Chem Lett; 2012 Jan; 22(2):1095-8. PubMed ID: 22189140
[TBL] [Abstract][Full Text] [Related]
18. N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2.
Boyd HF; Fell SC; Flynn ST; Hickey DM; Ife RJ; Leach CA; Macphee CH; Milliner KJ; Moores KE; Pinto IL; Porter RA; Rawlings DA; Smith SA; Stansfield IG; Tew DG; Theobald CJ; Whittaker CM
Bioorg Med Chem Lett; 2000 Nov; 10(22):2557-61. PubMed ID: 11086729
[TBL] [Abstract][Full Text] [Related]
19. Chiral iminoesters derived from D-glyceraldehyde in [3 + 2] cycloaddition reactions. Asymmetric synthesis of a key intermediate in the synthesis of neuramidinase inhibitors.
Gálvez JA; Díaz-de-Villegas MD; Alías M; Badorrey R
J Org Chem; 2013 Nov; 78(22):11404-13. PubMed ID: 24143968
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new biaryl scaffold generating potent renin inhibitors.
Lacombe P; Aspiotis R; Bayly C; Chen A; Dubé D; Fortin R; Gallant M; Juteau H; Liu S; McKay D; Roy P; Wu T
Bioorg Med Chem Lett; 2010 Oct; 20(19):5822-6. PubMed ID: 20728350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
